SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.18+1.0%9:42 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert S. who wrote (8070)12/15/1998 8:06:00 PM
From: Robert K.  Read Replies (4) of 17367
 
RobertS>besides the fact that many "potential" uses are in the trauma setting, I think that bpi products "may" be beneficial even looking into the cost/benefit approach. Shortened hospital stays, fewer complicatons,etc. Oh, I am sure there will be lots of studies.
Will provide a whole lotta work in DUR and disease state management. Look at liver and abdominal. Watch for surgery or perhaps cardio.
All IMO.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext